Medication Adherence Among Pediatric Post-Heart Transplant Patients in a Tertiary Care Hospital.

IF 1.1 4区 医学 Q3 SURGERY
Khawla Kahtani, Maha Al Ammari, Meshary Almeshary, Seena Thomas
{"title":"Medication Adherence Among Pediatric Post-Heart Transplant Patients in a Tertiary Care Hospital.","authors":"Khawla Kahtani, Maha Al Ammari, Meshary Almeshary, Seena Thomas","doi":"10.12659/AOT.946905","DOIUrl":null,"url":null,"abstract":"<p><p>BACKGROUND The present study assessed medication adherence to immunosuppressive therapy in pediatric patients following heart transplantation at a tertiary care center. MATERIAL AND METHODS A cross-sectional interview-based study combined with immunosuppressant level monitoring was conducted to encompass all pediatric patients who underwent heart transplants at King Abdulaziz Medical City-Central Region over a period of 5 months from January to May 2024. RESULTS More than 95% of patients' parents completed the questionnaire and were included in the final analysis. Among the pediatric post-heart transplant patients, 12 (60%) were males, aged from 6 to 18 years. Most patients (85%) were on tacrolimus, while 15% were on tacrolimus and sirolimus. Using the average blood serum drug levels and the ITAS, the prevalence of non-adherence was found to be 10% and 5%, respectively. Almost 95% of parents reported that they \"Never forget about taking immunosuppressive medication\". However, a small percentage reported occasional carelessness and missing administration of immunosuppressive medication to their children (5%). One reason given for stopping or missing medication were due to the child feeling worse in overall health (5%). CONCLUSIONS The results of this study indicate generally good adherence among pediatric post-heart transplant patients. Most participants demonstrated acceptable adherence behaviors. Continuous monitoring, support, and education are still necessary to maintain optimal adherence.</p>","PeriodicalId":7935,"journal":{"name":"Annals of Transplantation","volume":"30 ","pages":"e946905"},"PeriodicalIF":1.1000,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12659/AOT.946905","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND The present study assessed medication adherence to immunosuppressive therapy in pediatric patients following heart transplantation at a tertiary care center. MATERIAL AND METHODS A cross-sectional interview-based study combined with immunosuppressant level monitoring was conducted to encompass all pediatric patients who underwent heart transplants at King Abdulaziz Medical City-Central Region over a period of 5 months from January to May 2024. RESULTS More than 95% of patients' parents completed the questionnaire and were included in the final analysis. Among the pediatric post-heart transplant patients, 12 (60%) were males, aged from 6 to 18 years. Most patients (85%) were on tacrolimus, while 15% were on tacrolimus and sirolimus. Using the average blood serum drug levels and the ITAS, the prevalence of non-adherence was found to be 10% and 5%, respectively. Almost 95% of parents reported that they "Never forget about taking immunosuppressive medication". However, a small percentage reported occasional carelessness and missing administration of immunosuppressive medication to their children (5%). One reason given for stopping or missing medication were due to the child feeling worse in overall health (5%). CONCLUSIONS The results of this study indicate generally good adherence among pediatric post-heart transplant patients. Most participants demonstrated acceptable adherence behaviors. Continuous monitoring, support, and education are still necessary to maintain optimal adherence.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
0.00%
发文量
79
审稿时长
>12 weeks
期刊介绍: Annals of Transplantation is one of the fast-developing journals open to all scientists and fields of transplant medicine and related research. The journal is published quarterly and provides extensive coverage of the most important advances in transplantation. Using an electronic on-line submission and peer review tracking system, Annals of Transplantation is committed to rapid review and publication. The average time to first decision is around 3-4 weeks. Time to publication of accepted manuscripts continues to be shortened, with the Editorial team committed to a goal of 3 months from acceptance to publication. Expert reseachers and clinicians from around the world contribute original Articles, Review Papers, Case Reports and Special Reports in every pertinent specialty, providing a lot of arguments for discussion of exciting developments and controversies in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信